138 Bassirou Bonfoh et al. from humans and livestock, to relate human Brucellosis seropositivity and clinical symptoms in a highly endemic area like Kyrgyzstan and to monitor control policies for their effectiveness. ACKNOWLEDGMENTS This research is part of a project carried out within the Transversal Package Project ‘‘Pastoral Production Systems’’ co-funded by the Swiss National Centre of Competence in Research (NCCR) North–South: Research Partnerships for Mitigating Syndromes of Global Change, and the Swiss Agency for Development and Cooperation through Swiss Red Cross in Kyrgyzstan. We acknowledge the Afrique One Consortium for support. OPEN ACCESS This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and repro- duction in any medium, provided the original author(s) and source are credited. REFERENCES Almuneef MA, Memish ZA, Balkhy HH, Alotaibi B, Algoda S, Abbas M, Alsubaie S (2004) Importance of screening household members of acute brucellosis cases in endemic areas. Epidemi- ology and Infection 132:533–540 Alsubaie S, Almuneef M, Alshaalan M, Balkhy H, Albanyan E, Alola S, Alotaibi B, Memish ZA (2005) Acute brucellosis in Saudi families: relationship between brucella serology and clinical symptoms. International Journal of Infectious Disease 9:218–224 Bennett S, Woods T, Liyanage WM, Smith DL (1991) A simpliﬁed general method for cluster-sample surveys of health in devel- oping countries. Rapport Trimestriel de Statistiques Sanitaires Mondiales 44:98–106 Bonfoh B, Fane A, Traore AP, Tounkara K, Simbe CF, Alfaroukh IO, Schalch L, Farah Z, Nicolet J, Zinsstag J (2002) Use of an indirect enzyme immunoassay for detection of antibody to Brucella abortus in fermented cow milk. Milchwissenschaft 57:361–420 Corbel MJ (2006) Brucellosis in humans, animals, Geneva: WHO, FAO, OIE Habicht JP, Victora CG, Vaughan JP (1999) Evaluation designs for adequacy, plausibility and probability of public health pro- gramme performance and impact. International Journal of Epi- demiology 28:10–18 Kozukeev TB, Ajeilat S, Maes E, Favorov M (2006) Risk factors for brucellosis–Leylek and Kadamjay districts, Batken Oblast, Ky- rgyzstan, January–November, 2003. MMWR Morbidity and Mortality Weekly Report 55 Suppl 1, 31–34. Muench H (1959) Catalytic models in epidemiology, Cambridge, MA: Harvard University Press, pp 110 Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV (2006) The new global map of human brucellosis. The Lancet Infectious Diseases 6:91–99 Roth F, Zinsstag J, Orkhon D, Chimed-Ochir G, Hutton G, Cosivi O, Carrin G, Otte J (2003) Human health beneﬁts from live- stock vaccination for brucellosis: case study. Bulletin of the World Health Organization 81:867–876 Schelling E, Diguimbaye C, Daoud S, Nicolet J, Boerlin P, Tanner M, Zinsstag J (2003) Brucellosis and Q-fever seroprevalences of nomadic pastoralists and their livestock in Chad. Preventive Veterinary Medicine 61:279–293 Steinmann P, Bonfoh B, Farah Z, Peter O, Schelling E, Traore M, Zinsstag J (2005) Seroprevalence of Q-fever in febrile indi- viduals in Mali. Tropical Medicine & International Health 10(6):612–617 v.Oldershausen H-F (1968) Krankheiten durch Brucellen Teil B: Pathogenese und Klinik. In: Infektionskrankheiten Band II/1 Krankheiten durch Bakterien, Gsell O, Mohr W (editors), Berlin: Springer, pp 500–554 Zinsstag J, Roth F, Orkhon D, Chimed-Ochir G, Nansalmaa M, Kolar J, Vounatsou P (2005) A model of animal-human bru- cellosis transmission in Mongolia. Preventive Veterinary Medi- cine 69:77–95 Zinsstag J, Schelling E, Bonfoh B, Fooks AR, Kasymbekov J, Waltner-Toews D, Tanner M (2009) Towards a ‘‘one health’’ research and application tool box. Veterinaria Italiana 45:121– 133